PRe-ART SIGNED
Predictive Reagent Antibody Replacement Technology
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0PRe-ART project word cloud
Explore the words cloud of the PRe-ART project. It provides you a very rough idea of what is the project "PRe-ART" about.
Project "PRe-ART" data sheet
The following table provides information about the project.
| Coordinator |
UNIVERSITAT ZURICH
Organization address contact info |
| Coordinator Country | Switzerland [CH] |
| Project website | https://www.pre-art.uzh.ch |
| Total cost | 3˙588˙125 € |
| EC max contribution | 3˙588˙125 € (100%) |
| Programme |
1. H2020-EU.1.2.1. (FET Open) |
| Code Call | H2020-FETOPEN-1-2016-2017 |
| Funding Scheme | RIA |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-09-01 to 2021-08-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | UNIVERSITAT ZURICH | CH (ZURICH) | coordinator | 1˙428˙750.00 |
| 2 | ASTON UNIVERSITY | UK (BIRMINGHAM) | participant | 1˙189˙375.00 |
| 3 | UNIVERSITAT BAYREUTH | DE (BAYREUTH) | participant | 970˙000.00 |
Map
Project objective
Predictive Reagent Antibody Replacement Technology (PRe-ART) will create a foundational new technology platform to completely replace conventional antibody technology within medical diagnostics and basic life science research. In a multidisciplinary approach combining basic science, protein engineering and computational prediction, Pre-ART will generate non-antibody components which can be combined in an entirely modular fashion to create molecules that bind any peptide of choice. Such a biotechnological revolution is timely because of current failings in the reagent antibody market, after forty years still based on monoclonal antibodies (mAbs) to detect biomolecules, when 50% of all commercial reagent mAbs have been shown to not function correctly.
By combining information science with directed evolution, PRe-ART will ultimately create an encyclopedia of pre-designed and experimentally pre-selected modules (like biological Lego bricks) that may be combined, without any further experiment, to generate unique binding molecules that function as antibody replacements. The PRe-ART vision is that mAbs for many applications in biological research will be replaced over the course of a decade by these designer molecules, with the potential to completely disrupt the industry selling low-quality commercial animal-derived reagent antibodies, and thus create a major new technology for biological research.
Thus, PRe-ART will ultimately contribute not only to the health and wellbeing of the EU citizen through improved diagnostic capability, but also to the economy of the EU through the development of myriad detection products, enabled by this foundational platform technology. The interdisciplinary PRe-ART project will achieve this goal by bringing together three leading labs from different fields, two of which are lead by women PIs, whose joint efforts will achieve this breakthrough S&T target. The PRe-ART project thus closely addresses all specific challenges of the call.
Deliverables
| Project website and logo | Websites, patent fillings, videos etc. | 2020-02-27 11:42:50 |
| Two press releases / media actions launched and video online | Other | 2020-02-27 11:42:50 |
Take a look to the deliverables list in detail: detailed list of PRe-ART deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRE-ART" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PRE-ART" are provided by the European Opendata Portal: CORDIS opendata.